![](https://entrepreneurs.utoronto.ca/wp-content/uploads/2024/02/Square-logo.png)
HDAX Therapeutics
HDAX Therapeutics is a preclinical stage company pioneering next-gen precision therapeutics for diseases with microtubule dysfunction, such as neuropathies and cardiovascular diseases.
HDAX Therapeutics is a preclinical stage company pioneering next-gen precision therapeutics for diseases with microtubule dysfunction, such as neuropathies and cardiovascular diseases.